Advertisement
Screener

CytomX Therapeutics, Inc. (CTMX) Executive Pay versus Performance: Pay versus Performance

CytomX Therapeutics, Inc. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Sean A. McCarthy, D. Phil.; PEO total compensation $4.74M; PEO compensation actually paid $10.64M; Other NEO average total compensation $1.89M.
  • 2024-12-31: PEO Sean A. McCarthy, D. Phil.; PEO total compensation $1.75M; PEO compensation actually paid $1.06M; Other NEO average total compensation $861.32K.
  • 2023-12-31: PEO Sean A. McCarthy, D. Phil.; PEO total compensation $2.61M; PEO compensation actually paid $519.37K; Other NEO average total compensation $1.13M.
  • 2024-12-31: PEO Sean A. McCarthy, D. Phil.; PEO total compensation $1.75M; PEO compensation actually paid $1.06M; Other NEO average total compensation $861.32K.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Sean A. McCarthy, D. Phil.$4.74M$10.64M$1.89M$2.95M$266.252026-04-30
2024-12-31Sean A. McCarthy, D. Phil.$1.75M$1.06M$861.32K$611.44K$64.382026-04-30
2023-12-31Sean A. McCarthy, D. Phil.$2.61M$519.37K$1.13M$528.06K$96.882026-04-30
2024-12-31Sean A. McCarthy, D. Phil.$1.75M$1.06M$861.32K$611.44K$23.79$31.87M2025-04-28
2023-12-31Sean A. McCarthy, D. Phil.$2.61M$519.37K$1.13M$528.06K$35.80-$569.00K2025-04-28
2022-12-31Sean A. McCarthy, D. Phil.$3.01M$671.92K$1.38M$586.77K$36.95-$99.32M2025-04-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B